Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Cross-modal tactile-taste interactions in food evaluations.

Slocombe BG, Carmichael DA, Simner J.

Neuropsychologia. 2016 Jul 29;88:58-64. doi: 10.1016/j.neuropsychologia.2015.07.011. Epub 2015 Jul 10.

2.
3.
4.

The future of antibacterial chemotherapy.

Slocombe B.

Zentralbl Bakteriol. 1994 Oct;281(3):346-52. Review. No abstract available.

PMID:
7696756
5.

A clarithromycin sensitivity survey.

Durodie J, Slocombe B.

J Antimicrob Chemother. 1994 Sep;34(3):446. No abstract available.

PMID:
7829421
6.

The use of in-vitro kinetic models in the evaluation of beta-lactam/beta-lactamase inhibitor combinations.

Thorburn CE, Slocombe B.

Adv Exp Med Biol. 1994;349:157-62. No abstract available.

PMID:
8209803
7.

High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.

Gilbart J, Perry CR, Slocombe B.

Antimicrob Agents Chemother. 1993 Jan;37(1):32-8.

8.

The antimicrobial activity of mupirocin--an update on resistance.

Slocombe B, Perry C.

J Hosp Infect. 1991 Sep;19 Suppl B:19-25. Review.

PMID:
1684187
9.
10.
12.

Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase.

Slocombe B, Cooper CE, Masters PJ, Warrack JD.

J Chemother. 1989 Jul;1(4 Suppl):353-4. No abstract available.

PMID:
16312436
13.
14.
15.

Bactericidal effects of amoxycillin/clavulanic acid (augmentin) against Legionella pneumophila in vitro and in tissue culture studies.

Stokes DH, Wilkinson MJ, Slocombe B, Sutherland R.

J Chemother. 1989 Jul;1(4 Suppl):84-5. No abstract available.

PMID:
16312315
16.

Synergy between ticarcillin/clavulanic acid and aminoglycosides against Pseudomonas aeruginosa infections in neutropenic mice.

Smith GM, Beale AS, Slocombe B.

J Chemother. 1989 Jul;1(4 Suppl):82-3. No abstract available.

PMID:
16312314
17.

Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.

Griffin KE, Cooper CE, Slocombe B.

J Chemother. 1989 Jul;1(4 Suppl):71-3. No abstract available.

PMID:
16312309
18.

Comparative activities in vitro of amoxycillin/clavulanic acid and ampicillin/sulbactam.

Masters PJ, Cooper CE, Griffin KE, Slocombe B, Sutherland R.

J Chemother. 1989 Jul;1(4 Suppl):67-9. No abstract available.

PMID:
16312307
19.

Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies.

Stokes DH, Wilkinson MJ, Tyler J, Slocombe B, Sutherland R.

J Antimicrob Chemother. 1989 Apr;23(4):547-56.

PMID:
2745260
20.

Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila.

Stokes DH, Slocombe B, Sutherland R.

J Antimicrob Chemother. 1989 Jan;23(1):43-51.

PMID:
2745255
21.

The evolution of antibiotic production and public health problems.

Mansford KR, Slocombe B.

Chemioterapia. 1987 Jun;6(3):234-40.

PMID:
3496977
22.

Structure-activity relationships of some 6 alpha-formamido penicillins.

Guest AW, Harrington FP, Milner PH, Ponsford RJ, Smale TC, Stachulski AV, Basker MJ, Slocombe B.

J Antibiot (Tokyo). 1986 Oct;39(10):1498-501. No abstract available.

23.

Antibacterial activity of resolved temocillin epimers.

White AR, Cooper CE, Griffin KE, Slocombe B.

J Antimicrob Chemother. 1986 Sep;18(3):335-43.

PMID:
3533885
24.

BRL 20330, an oral prodrug of temocillin: bioavailability studies in man.

Basker MJ, Merrikin DJ, Ponsford RJ, Slocombe B, Tasker TC.

J Antimicrob Chemother. 1986 Sep;18(3):399-405.

PMID:
3095301
25.

Inhibition of beta-lactamases in Branhamella catarrhalis.

Slocombe B.

Drugs. 1986;31 Suppl 3:79-81. No abstract available.

PMID:
3488200
26.

Antibacterial activity of ticarcillin in the presence of clavulanate potassium.

Sutherland R, Beale AS, Boon RJ, Griffin KE, Slocombe B, Stokes DH, White AR.

Am J Med. 1985 Nov 29;79(5B):13-24.

PMID:
3878080
27.

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR.

Antimicrob Agents Chemother. 1985 Apr;27(4):495-8.

28.

Human pharmacokinetics of temocillin (BRL 17421) side chain epimers.

Guest EA, Horton R, Mellows G, Slocombe B, Swaisland AJ, Tasker TC.

J Antimicrob Chemother. 1985 Mar;15(3):327-36.

PMID:
3997707
29.

Human pharmacokinetics and antimicrobial activities of the temocillin epimers.

Guest EA, Horton R, Mellows G, Slocombe B, Swaisland AJ, Tasker TC, White AR.

Drugs. 1985;29 Suppl 5:154-61.

PMID:
4029021
30.

Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.

White AR, Stokes DH, Slocombe B, Sutherland R.

J Antimicrob Chemother. 1985 Jan;15 Suppl A:227-32.

PMID:
3980328
31.

Temocillin. In vitro antibacterial activity.

Slocombe B, Cooper CE, Griffin KE, White AR.

Drugs. 1985;29 Suppl 5:49-56.

PMID:
3849425
32.

In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.

Basker MJ, Edmondson RA, Knott SJ, Ponsford RJ, Slocombe B, White SJ.

Antimicrob Agents Chemother. 1984 Nov;26(5):734-40.

33.

BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Slocombe B, Basker MJ, Bentley PH, Clayton JP, Cole M, Comber KR, Dixon RA, Edmondson RA, Jackson D, Merrikin DJ, Sutherland R.

Antimicrob Agents Chemother. 1981 Jul;20(1):38-46.

34.

Aminoglycoside-resistant enterococci.

Basker MJ, Slocombe B, Sutherland R.

J Clin Pathol. 1977 Apr;30(4):375-80.

35.

A double trial of amoxycillin in the treatment of gonorrhoea.

Thin RN, Symonds MA, Shaw EJ, Wong J, Hopper PK, Slocombe B.

Br J Vener Dis. 1977 Apr;53(2):118-20.

36.

Transferable antibiotic resistance in enteropathogenic Escherichia coli between 1948 and 1968.

Slocombe B, Sutherland R.

Antimicrob Agents Chemother. 1973 Oct;4(4):459-66.

37.

R-factor mediated beta-lactamase in Pseudomonas aeruginosa.

Fullbrook PD, Elson SW, Slocombe B.

Nature. 1970 Jun 13;226(5250):1054-6. No abstract available.

PMID:
4986643
38.

Sensitivity of Gram-negative bacilli to ampicillin after six years' clinical use.

Slocombe B, Sutherland R.

J Clin Pathol. 1969 Nov;22(6):644-8.

39.

Beta-lactamase activity and resistance to ampicillin, carbenicillin, and cephaloridine of Klebsiella, Enterobacter, and Citrobacter.

Slocombe B, Sutherland R.

Antimicrob Agents Chemother (Bethesda). 1969;9:78-85. No abstract available.

PMID:
5202413
40.

DEVELOPMENT IN VITRO OF BACTERIAL CROSS-RESISTANCE INVOLVING PENICILLINS, CHLORAMPHENICOL AND TETRACYCLINE.

SUTHERLAND R, SLOCOMBE B, ROLINSON GN.

Nature. 1964 Aug 1;203:548-9. No abstract available.

PMID:
14208284

Supplemental Content

Loading ...
Support Center